D'Orazio & Associates, Inc. Abbott Laboratories Transaction History

D'Orazio & Associates, Inc.

$703 Million
Q3 2024

A detailed history of D'Orazio & Associates, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, D'Orazio & Associates, Inc. holds 4,299 shares of ABT stock, worth $493,353. This represents 0.07% of its overall portfolio holdings.

Number of Shares

4,299

Previous 5,279 18.56%

Holding current value

$493,353

Previous $548,000 10.58%

% of portfolio

0.07%

Previous 0.08%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$100.07 - $118.13 $98,068 - $115,767	-980 Reduced 18.56%	4,299 $490,000
Q2 2024 Aug 07, 2024	BUY	$100.73 - $112.44 $81,490 - $90,963	809 Added 18.1%	5,279 $548,000
Q1 2024 May 08, 2024	BUY	$109.52 - $120.96 $61,112 - $67,495	558 Added 14.26%	4,470 $508,000
Q4 2023 Feb 07, 2024	BUY	$90.19 - $110.4 $103,898 - $127,180	1,152 Added 41.74%	3,912 $430,000
Q3 2023 Oct 10, 2023	SELL	$95.53 - $114.62 $149,217 - $179,036	-1,562 Reduced 36.14%	2,760 $267,000
Q2 2023 Aug 04, 2023	BUY	$100.78 - $112.29 $207,102 - $230,755	2,055 Added 90.65%	4,322 $471,000
Q1 2023 Apr 21, 2023	SELL	$96.86 - $114.01 $107,611 - $126,665	-1,111 Reduced 32.89%	2,267 $229,000
Q4 2022 Jan 25, 2023	SELL	$95.06 - $111.52 $10,551 - $12,378	-111 Reduced 3.18%	3,378 $0
Q3 2022 Oct 13, 2022	BUY	$96.76 - $112.03 $84,181 - $97,466	870 Added 33.22%	3,489 $338,000
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $18,066 - $21,836	177 Added 7.25%	2,619 $285,000
Q1 2022 May 02, 2022	SELL	$114.02 - $139.04 $61,912 - $75,498	-543 Reduced 18.19%	2,442 $289,000
Q4 2021 Feb 07, 2022	BUY	$115.53 - $141.46 $51,410 - $62,949	445 Added 17.52%	2,985 $420,000
Q3 2021 Nov 10, 2021	BUY	$116.66 - $129.06 $48,180 - $53,301	413 Added 19.42%	2,540 $300,000
Q2 2021 Aug 04, 2021	BUY	$105.79 - $124.53 $105 - $124	1 Added 0.05%	2,127 $247,000
Q1 2021 May 05, 2021	BUY	$108.84 - $128.23 $108 - $128	1 Added 0.05%	2,126 $255,000
Q4 2020 Feb 05, 2021	BUY	$105.0 - $114.42 $210 - $228	2 Added 0.09%	2,125 $233,000
Q3 2020 Oct 19, 2020	SELL	$91.64 - $111.29 $458 - $556	-5 Reduced 0.23%	2,123 $231,000
Q2 2020 Jul 22, 2020	BUY	$76.57 - $98.0 $535 - $686	7 Added 0.33%	2,128 $195,000
Q1 2020 Apr 28, 2020	BUY	$62.82 - $91.86 $62 - $91	1 Added 0.05%	2,121 $167,000
Q4 2019 Jan 22, 2020	BUY	$78.51 - $87.4 $157 - $174	2 Added 0.09%	2,120 $184,000
Q3 2019 Nov 01, 2019	BUY	$81.84 - $88.74 $27,089 - $29,372	331 Added 18.52%	2,118 $177,000
Q1 2019 May 01, 2019	BUY	$66.22 - $80.06 $99,330 - $120,090	1,500 Added 522.65%	1,787 $143,000
Q4 2017 Feb 06, 2018	BUY	$53.68 - $57.47 $10,736 - $11,494	200 Added 229.89%	287 $16,000
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $4,181 - $4,666	87	87 $5,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D'Orazio & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on D'Orazio & Associates, Inc. with notifications on news.

Account

D'Orazio & Associates, Inc. Abbott Laboratories Transaction History